CYP19A1 and breast cancer: Chottanapund and colleagues (59) have evaluated the aromatase suppressive effects of melatonin on hormonal positive breast cancer cells and have shown that melatonin was as potent as letrozole in inhibiting aromatization of androgen to estrogen.